Literature DB >> 22532687

Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein.

Takashi Irie1, Katsuhiro Kiyotani, Tomoki Igarashi, Asuka Yoshida, Takemasa Sakaguchi.   

Abstract

The V protein of Sendai virus (SeV) suppresses innate immunity, resulting in enhancement of viral growth in mouse lungs and viral pathogenicity. The innate immunity restricted by the V protein is induced through activation of interferon regulatory factor 3 (IRF3). The V protein has been shown to interact with melanoma differentiation-associated gene 5 (MDA5) and to inhibit beta interferon production. In the present study, we infected MDA5-knockout mice with V-deficient SeV and found that MDA5 was largely unrelated to the innate immunity that the V protein suppresses in vivo. We therefore investigated the target of the SeV V protein. We previously reported interaction of the V protein with IRF3. Here we extended the observation and showed that the V protein appeared to inhibit translocation of IRF3 into the nucleus. We also found that the V protein inhibited IRF3 activation when induced by a constitutive active form of IRF3. The V proteins of measles virus and Newcastle disease virus inhibited IRF3 transcriptional activation, as did the V protein of SeV, while the V proteins of mumps virus and Nipah virus did not, and inhibition by these proteins correlated with interaction of each V protein with IRF3. These results indicate that IRF3 is important as an alternative target of paramyxovirus V proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532687      PMCID: PMC3416347          DOI: 10.1128/JVI.06705-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis.

Authors:  J Curran; J B Marq; D Kolakofsky
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

2.  Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity.

Authors:  S Vidal; J Curran; D Kolakofsky
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity.

Authors:  K Kiyotani; S Takao; T Sakaguchi; T Yoshida
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

6.  Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis, and efficient RNA editing.

Authors:  Noriko Fukuhara; Cheng Huang; Katsuhiro Kiyotani; Tetsuya Yoshida; Takemasa Sakaguchi
Journal:  Virology       Date:  2002-08-01       Impact factor: 3.616

7.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

8.  Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein.

Authors:  Fumihiro Sugahara; Tsuneo Uchiyama; Hitoshi Watanabe; Yukie Shimazu; Masaru Kuwayama; Yutaka Fujii; Katsuhiro Kiyotani; Akio Adachi; Nobuoki Kohno; Tetsuya Yoshida; Takemasa Sakaguchi
Journal:  Virology       Date:  2004-07-20       Impact factor: 3.616

9.  The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing.

Authors:  J Curran; R Boeck; D Kolakofsky
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

10.  Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5.

Authors:  S M Thomas; R A Lamb; R G Paterson
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

View more
  30 in total

Review 1.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

Review 2.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

3.  Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway.

Authors:  Suruchi N Schock; Neha V Chandra; Yuefang Sun; Takashi Irie; Yoshinori Kitagawa; Bin Gotoh; Laurent Coscoy; Astar Winoto
Journal:  Cell Death Differ       Date:  2017-01-06       Impact factor: 15.828

Review 4.  Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses.

Authors:  Srirupa Chatterjee; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  J Mol Biol       Date:  2016-07-31       Impact factor: 5.469

5.  A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.

Authors:  Asuka Yoshida; Ryoko Kawabata; Tomoyuki Honda; Kouji Sakai; Yasushi Ami; Takemasa Sakaguchi; Takashi Irie
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon.

Authors:  Jaime L Wetzel; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

7.  Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.

Authors:  Takayuki Komatsu; Yukie Tanaka; Yoshinori Kitagawa; Naoki Koide; Yoshikazu Naiki; Naoko Morita; Bin Gotoh; Takashi Yokochi
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 8.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

9.  Human parainfluenza virus type 2 V protein inhibits TRAF6-mediated ubiquitination of IRF7 to prevent TLR7- and TLR9-dependent interferon induction.

Authors:  Yoshinori Kitagawa; Mayu Yamaguchi; Min Zhou; Machiko Nishio; Masae Itoh; Bin Gotoh
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine.

Authors:  Ting-Hin Ho; Chun Kew; Pak-Yin Lui; Chi-Ping Chan; Takashi Satoh; Shizuo Akira; Dong-Yan Jin; Kin-Hang Kok
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.